Following the connections between organ systems
LinkedIn caption
🩺 Following the connections between organ systems
Ariel Feldstein’s contribution to the ARDD 2026 Pharma Chief Executive Panel focused on the links between cardiac, renal, metabolic and neurological health. He used GLP-1 therapies to discuss the value of considering these connected systems together when developing treatments.
💡 He also pointed to large-scale real-world data and AI as tools for investigating why people follow different aging trajectories. The research opportunity is to connect patterns across those systems and identify where earlier intervention might be useful.
The wider panel examined the practical barriers to prevention, including long trial timelines, meaningful endpoints and reimbursement. Feldstein’s comments placed multi-system biology within that discussion about how research can support a more preventive approach to medicine.
#ARDD2026 #DrugDiscovery
X caption
🩺 Ariel Feldstein connected cardiac, renal, metabolic and neurological health at #ARDD2026, discussing GLP-1 therapies and how real-world data plus AI could inform earlier intervention. Connected systems can change how we frame earlier intervention.
Credit: Michael DeStefano
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.
